Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
|
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15.06.15 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 28.05.14 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 15.02.23 |
Jarrod Longcor
COO | Chief Operating Officer | 51 | 15.07.16 |
Shane Lea
PRN | Corporate Officer/Principal | - | 21.11.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 07.04.17 |
Douglas Swirsky
CHM | Chairman | 54 | 07.04.17 |
John Neis
BRD | Director/Board Member | 68 | 01.02.08 |
James Caruso
CEO | Chief Executive Officer | 65 | 15.06.15 |
Stefan Loren
BRD | Director/Board Member | 60 | 15.06.15 |
Director/Board Member | 55 | 24.06.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 238 | 0 | 0 | 90,91 % |
Aktie B | 0 | 111 | 0 | 0 | |
Aktie C | 1 | 35 848 924 | 32 591 316 ( 90,91 %) | 0 |
Unternehmenskontakt
![Straße Cellectar Biosciences Inc](https://cdn.zonebourse.com/static/address/17516065.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+50.70% | 791 Mrd. | |
+41.96% | 630 Mrd. | |
-7.15% | 350 Mrd. | |
+18.77% | 328 Mrd. | |
+8.79% | 298 Mrd. | |
+18.02% | 246 Mrd. | |
+1.27% | 225 Mrd. | |
+11.95% | 218 Mrd. | |
+3.68% | 160 Mrd. |
- Börse
- Aktien
- A3DQSD Aktie
- Aktie
- Unternehmen Cellectar Biosciences Inc